Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo

Journal of Biological Chemistry

Volumn 288, Issue 48, 2013, Pages 34460-34469

  Tsou, Wei Ling ^a   Burr, Aaron A ^a   Ouyang, Michelle ^a   Blount, Jessica R ^a   Scaglione, K Matthew ^b   Todi, Sokol V ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C TERMINUS; CELLULAR PROCESS; DROSOPHILA MELANOGASTER; LYSINE RESIDUES; PROTEASE ACTIVITIES; TOXIC PROTEINS; UBIQUITIN LIGASES; UBIQUITINATION;

AMINO ACIDS; PHYSIOLOGY;

PROTEINS;

ATAXIN 3; HEAT SHOCK COGNATE PROTEIN 70; LYSINE; POLYGLUTAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; ENZYME REGULATION; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; UBIQUITINATION; WESTERN BLOTTING;

EID: 84889049439     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.513903     Document Type: Article

References (43)

1. Todi, S. V., and Paulson, H. L. (2011) Balancing act: deubiquitinating enzymes in the nervous system. Trends Neurosci. 34, 370-382
2. Clague, M. J., Coulson, J. M., and Urbé, S. (2012) Cellular functions of the DUBs. J. Cell Sci. 125, 277-286
3. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K., and Bernards, R. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786
4. Sacco, J. J., Coulson, J. M., Clague, M. J., and Urbé, S. (2010) Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life 62, 140-157
5. Clague, M. J., Barsukov, I., Coulson, J. M., Liu, H., Rigden, D. J., and Urbé, S. (2013) Deubiquitylases from genes to organism. Physiol. Rev. 93, 1289-1315
6. Lee, B. H., Lee, M. J., Park, S., Oh, D. C., Elsasser, S., Chen, P. C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., Wilson, S. M., King, R. W., and Finley, D. (2010) Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179-184
7. Todi, S., and Das, C. (2012) Should deubiquitinating enzymes be targeted for therapy? Clin. Pharmacol. Biopharmaceutics 1, 1000e108
8. Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., Calabrese, A., Borg-Capra, C., Sippl, W., Collura, V., Boissy, G., Rain, J. C., Guedat, P., Delansorne, R., and Daviet, L. (2009) Small-molecule inhibitor of USP7/ HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol. Cancer Ther. 8, 2286-2295
9. Kessler, B. M., and Edelmann, M. J. (2011) PTMs in conversation: activity and function of deubiquitinating enzymes regulated via post-translational modifications. Cell Biochem. Biophys. 60, 21-38
10. Seki, T., Gong, L., Williams, A. J., Sakai, N., Todi, S. V., and Paulson, H. L. (2013) JosD1, a membrane-targeted deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility and endocytosis. J. Biol. Chem. 288, 17145-17155
11. Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., and Paulson, H. L. (2009) Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J. 28, 372-382
12. Sowa, M. E., Bennett, E. J., Gygi, S. P., and Harper, J. W. (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403
13. Todi, S. V., Scaglione, K. M., Blount, J. R., Basrur, V., Conlon, K. P., Pastore, A., Elenitoba-Johnson, K., and Paulson, H. L. (2010) Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117. J. Biol. Chem. 285, 39303-39313
14. Meray, R. K., and Lansbury, P. T., Jr. (2007) Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCHL1. J. Biol. Chem. 282, 10567-10575
15. Denuc, A., Bosch-Comas, A., Gonzàlez-Duarte, R., and Marfany, G. (2009) The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS One 4, e5571
16. Costa Mdo, C., and Paulson, H. L. (2012) Toward understanding Machado-Joseph disease. Prog. Neurobiol. 97, 239-257
17. Warrick, J. M., Morabito, L. M., Bilen, J., Gordesky-Gold, B., Faust, L. Z., Paulson, H. L., and Bonini, N. M. (2005) Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell 18, 37-48
18. Todi, S. V., Williams, A., and Paulson, H. (2007) in Molecular Neurology (Waxman, S. G., ed) 1st Ed., pp. 257-276, Academic Press, London
19. Williams, A. J., and Paulson, H. L. (2008) Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 31, 521-528
20. Scaglione, K. M., Zavodszky, E., Todi, S. V., Patury, S., Xu, P., Rodríguez- Lebrón, E., Fischer, S., Konen, J., Djarmati, A., Peng, J., Gestwicki, J. E., and Paulson, H. L. (2011) Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 43, 599-612
21. Winborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., Cohen, R. E., Peng, J., and Paulson, H. L. (2008) The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys-63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 283, 26436-26443
22. Todi, S. V., Laco, M. N., Winborn, B. J., Travis, S. M., Wen, H. M., and Paulson, H. L. (2007) Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity. J. Biol. Chem. 282, 29348-29358
23. Blount, J. R., Burr, A. A., Denuc, A., Marfany, G., and Todi, S. V. (2012) Ubiquitin-specific protease 25 functions in endoplasmic reticulum-associated degradation. PLoS One 7, e36542
24. Todi, S. V., Franke, J. D., Kiehart, D. P., and Eberl, D. F. (2005) Myosin VIIA defects, which underlie the Usher 1B syndrome in humans, lead to deafness in Drosophila. Curr. Biol. 15, 862-868
25. Todi, S. V., Sivan-Loukianova, E., Jacobs, J. S., Kiehart, D. P., and Eberl, D. F. (2008) Myosin VIIA, important for human auditory function, is necessary for Drosophila auditory organ development. PLoS One 3, e2115
26. Tsou, W. L., Sheedlo, M. J., Morrow, M. E., Blount, J. R., McGregor, K. M., Das, C., and Todi, S. V. (2012) Systematic analysis of the physiological importance of deubiquitinating enzymes. PLoS One 7, e43112
27. Brand, A. H., and Perrimon, N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415
28. Warrick, J. M., Paulson, H. L., Gray-Board, G. L., Bui, Q. T., Fischbeck, K. H., Pittman, R. N., and Bonini, N. M. (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939-949
29. Berke, S. J., Schmied, F. A., Brunt, E. R., Ellerby, L. M., and Paulson, H. L. (2004) Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J. Neurochem. 89, 908-918
30. Pozzi, C., Valtorta, M., Tedeschi, G., Galbusera, E., Pastori, V., Bigi, A., Nonnis, S., Grassi, E., and Fusi, P. (2008) Study of subcellular localization and proteolysis of ataxin-3. Neurobiol. Dis. 30, 190-200
31. Gatchel, J. R., and Zoghbi, H. Y. (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743-755
32. Romero, E., Cha, G. H., Verstreken, P., Ly, C. V., Hughes, R. E., Bellen, H. J., and Botas, J. (2008) Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 57, 27-40
33. Li, L. B., Xu, K., and Bonini, N. M. (2007) Suppression of polyglutamine toxicity by the yeast Sup35 prion domain in Drosophila. J. Biol. Chem. 282, 37694-37701
34. McGurk, L., and Bonini, N. M. (2012) Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila. Hum. Mol. Genet. 21, 76-84
35. Connell, P., Ballinger, C. A., Jiang, J., Wu, Y., Thompson, L. J., Höhfeld, J., and Patterson, C. (2001) The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 3, 93-96
36. Dickey, C. A., Patterson, C., Dickson, D., and Petrucelli, L. (2007) Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol. Med. 13, 32-38
37. Burnett, B. G., and Pittman, R. N. (2005) The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc. Natl. Acad. Sci. U.S.A. 102, 4330-4335
38. Reina, C. P., Zhong, X., and Pittman, R. N. (2010) Proteotoxic stress increases nuclear localization of ataxin-3. Hum. Mol. Genet. 19, 235-249
39. Cemal, C. K., Carroll, C. J., Lawrence, L., Lowrie, M. B., Ruddle, P., Al- Mahdawi, S., King, R. H., Pook, M. A., Huxley, C., and Chamberlain, S. (2002) YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum. Mol. Genet. 11, 1075-1094
40. Lang, A. E., Rogaeva, E. A., Tsuda, T., Hutterer, J., and St George-Hyslop, P. (1994) Homozygous inheritance of the Machado-Joseph disease gene. Ann. Neurol. 36, 443-447
41. França, M. C., Jr., Emmel, V. E., D'Abreu, A., Maurer-Morelli, C. V., Secolin, R., Bonadia, L. C., da Silva, M. S., Nucci, A., Jardim, L. B., Saraiva- Pereira, M. L., Marques, W., Jr., Paulson, H., and Lopes-Cendes, I. (2012) Normal ATXN3 allele but not CHIP polymorphisms modulates age at onset in Machado-Joseph disease. Front. Neurol. 3, 164
42. Hübener, J., and Riess, O. (2010) Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models. Neurobiol. Dis. 38, 116-124
43. Franke, J. D., Montague, R. A., and Kiehart, D. P. (2005) Nonmuscle myosin II generates forces that transmit tension and drive contraction in multiple tissues during dorsal closure. Curr. Biol. 15, 2208-2221